Audentes Therapeutics, Inc. announced the appointment of Scott Morrison to its board of directors. Mr. Morrison will serve as chairman of the Audentes Therapeutics audit committee. Mr. Morrison was a Partner with Ernst & Young LLP from 1996 to December 2015.
Audentes Therapeutics, Inc.
Equities
US05070R1041
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.35% | 22.28B | |
-5.61% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |